| European Case Law Identifier: | ECLI:EP:BA:2005:T015703.20050104 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 04 January 2005 | ||||||||
| Case number: | T 0157/03 | ||||||||
| Application number: | 93902779.3 | ||||||||
| IPC class: | A61K 38/45 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | C | ||||||||
| Download and more information: |
|
||||||||
| Title of application: | Methods and compositions for reducing blood loss | ||||||||
| Applicant name: | ZYMOGENETICS, INC. | ||||||||
| Opponent name: | 01 Baxter Aktiengesellschaft 02 Aventis Behring GmbH |
||||||||
| Board: | 3.3.04 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Admissibility of late filed documents (no) Sufficiency of disclosure (yes) Novelty (yes) Inventive step (yes) |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t030157eu1.html
Date retrieved: 17 May 2021